Chart Scan – Oct 25, 2022
ACB – Aurora Cannabis Inc.
ADN – Advent Technologies Holdings, Inc.
ADPT – Adaptive Biotechnologies Corp.
AKTS – Akoustis Technologies, Inc.
AMRS – Amyris Inc.
APPH – AppHarvest, Inc.
ARAV – Aravive, Inc.
ARBK – Argo Blockchain Plc
ARVL – Arrival Ltd.
ATAI – ATAI Life Sciences N.V.
AUR – Aurora Innovation, Inc.
AVDX – AvidXchange Holdings Inc.
AVPT – AvePoint Inc.
BBBY – Bed Bath & Beyond, Inc.
BGRY – Berkshire Grey, Inc.
BITF – Bitfarms Ltd.
BLU – BELLUS Health, Inc.
BNGO – Bionano Genomics, Inc.
BTBT – Bit Digital Inc.
CDXS – Codexis Inc.
CHRS – Coherus BioSciences Inc.
CLOV – Clover Health Investments Corp.
CLSK – CleanSpark, Inc.
CLXT – Calyxt, Inc.
CRIS – Curis, Inc.
CRON – Cronos Group Inc.
DUO – Fangdd Network Group Ltd
EGIO – Edgio, Inc.
EOSE – Eos Energy Enterprises, Inc.
FLGC – Flora Growth Corp.
GDRX – GoodRx Holdings, Inc.
GEVO – Gevo Inc.
GOCO – GoHealth Inc.
GRTS – Gritstone bio, Inc.
HIVE – HIVE Blockchain Technologies Ltd.
HUT – Hut 8 Mining Corp.
HYZN – Hyzon Motors Inc.
IOVA – Iovance Biotherapeutics, Inc.
LPSN – LivePerson, Inc.
MOB – Mobilicom Limited
NEO – NeoGenomics, Inc.
NKTR – Nektar Therapeutics
OCGN – Ocugen Inc.
OPEN – Opendoor Technologies Inc.
OPGN – OpGen, Inc.
PAYO – Payoneer Global Inc.
PNT – POINT Biopharma Global Inc.
POWW – AMMO, Inc.
PRTS – CarParts.com
PSNY – Polestar Automotive Holding UK Plc
PTPI – Petros Pharmaceuticals Inc.
QRTEA – Qurate Retail, Inc.
QSI – HighCape Capital Acquisition Corp.
RCON – Recon Technology Ltd.
RDFN – Redfin Corp
REE – REE Automotive Ltd
REVB – Revelation Biosciences Inc.
RIOT – Riot Blockchain, Inc.
RKLB – Rocket Lab USA, Inc.
RNLX – Renalytix AI Plc
ROIV – Roivant Sciences Ltd.
SANA – Sana Biotechnology Inc.
SLGC – SomaLogic, Inc.
TLRY – Tilray, Inc.
TSHA – Taysha Gene Therapies Inc.
VIEW – View, Inc.
VLDR – Velodyne Lidar, Inc.
VMEO – Vimeo Inc.
VSTM – Verastem Inc.
VTRS – Viatris Inc.
WATT – Energous Corp.
WKHS – Workhorse Group Inc.
YELL – Yellow Corporation
Disclaimer:
We have not received any form of compensation for the generation of this blog
Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.
Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.
We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.